Researchers from Oregon State University and Oregon Health & Science University have developed a method for producing nanoparticles that can reach temperatures in cancer lesions of up to 50 degrees Celsius (122 degrees Fahrenheit) when exposed to an alternating magnetic field. Magnetic nanoparticles have shown anti-cancer potential for years, but they can only be used in patients whose tumors are accessible by a hypodermic needle (that is, not for people with hard-to-reach malignancies, such as metastatic ovarian cancer). In the case of this study, the nanoparticles can accumulate in metastatic ovarian cancer tumors and, when exposed to an alternating magnetic field, can rise in temperature to 50 degrees Celsius.
An official website of the United States government.